Coronavirus | Covaxin effective against the U.K. variant, says study

Researchers from ICMR’s Pune-based National Institute of Virology (NIV) and Bharat Biotech found that the vaccine has “comparable neutralisation activity” against the UK variant and the strain used for making the vaccine.